The 2nd International iFIT Conference brings together leading scientists, clinician scientists, physicians, early-career researchers, students, industry innovators, and strategic partners from around the world to discuss the latest advances in cancer research and therapy development.
Hosted by the Cluster of Excellence iFIT-Image-Guided and Functionally Instructed Tumor Therapies, the conference reflects iFIT’s unique interdisciplinary approach to developing next-generation cancer therapies by integrating functional target discovery, academic drug development, cancer immunotherapy, and molecular and functional imaging. The meeting provides an international platform to exchange ideas, showcase scientific breakthroughs, and foster collaborations that accelerate the translation of discoveries from the laboratory into clinical application.
Despite remarkable progress in oncology, advanced and metastatic cancers remain among the greatest challenges in medicine. Therapy resistance, tumor heterogeneity, and the complexity of the tumor microenvironment continue to limit long-term treatment success. Addressing these challenges requires close collaboration across disciplines.
The iFIT research concept combines expertise in:
- Functional target discovery and academic drug development
- Cancer immunology and next-generation immunotherapies
- Molecular and functional multiparametric imaging
- Artificial intelligence and data-driven approaches
- Translational and clinical cancer research
By integrating these complementary research fields, iFIT creates a unique environment where fundamental discoveries can be transformed into innovative diagnostics, therapeutic strategies, and early clinical applications.
The conference welcomes participants from across the international biomedical community, including:
- Basic and translational researchers
- Clinician scientists and healthcare professionals
- PhD students and postdoctoral researchers
- Principal investigators and academic leaders
- Industry scientists and biotechnology partners
- Pharmaceutical and technology companies
- Innovation, regulatory and clinical trial experts
Whether you are beginning your scientific career or leading an established research program, the conference offers valuable opportunities to exchange knowledge, establish collaborations, and explore new research directions.
Participants can look forward to an exciting scientific program featuring internationally renowned keynote speakers, cutting-edge research presentations, interactive discussions, poster sessions, and networking events.
The conference is designed to promote interdisciplinary dialogue and encourage interactions across different research fields and sectors. Dedicated networking opportunities will facilitate connections between academia, clinical research, industry, and technology developers, creating an environment where new collaborations and innovative ideas can emerge.
Early-career researchers will have the opportunity to present their work, receive feedback from internationally recognized experts, expand their professional networks, and explore future career opportunities in academia, clinical research, and industry.
With participants expected from leading universities, research institutes, hospitals, biotechnology companies, and pharmaceutical organizations worldwide, the conference provides an international forum for discussing the future of precision oncology and translational cancer research.